Mike's deep project experience includes R&D Portfolio Prioritization, Commercial Development and Launch Plans, and Growth Strategy for In-line Brands.
Mike has prepared and/or implemented plans for new businesses and/or products in most therapeutic areas as well as assisted with strategic M&A/L&A transactions including assessment/valuation, due diligence, partnering and negotiation support.
He also has experience as a member of the board of directors of both public and private Biopharma, Diagnostics and Device companies. He currently serves on the Board of Trustees of the New Bedford Symphony Orchestra and is a member of the Corporation of MCPHS University.
BACKContact us today to learn how our pharma & biotech consulting expertise can serve your project.
Contact us© 2019 Alacrita Holdings Limited | Life Science, Biotech & Pharmaceutical Consulting
Alacrita Consulting
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
303 Wyman Street
Waltham, MA
02451
Registered in Massachusetts.
Rue du Château 20
1814 La Tour-de-Peilz
Switzerland
Registered in Switzerland.
No. CHE-233.138.008